News Focus
News Focus
icon url

mick

03/21/23 1:29 PM

#596149 RE: mick #596083

***** Was $0.034 /\ courtesy of Z / $PPCB /
https://seekingalpha.com/symbol/PPCB
https://www.otcmarkets.com/stock/PPCB
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171398268
Thursday, March 09, 2023 8:37:30 AM
52WK RANGE 0.0002 - 0.0339



[-chart]ddamanda.com/Charts/DDAmandaPPCB.jpg[/chart]

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171398268

http://www.propanc.com
61-03- 9882-0780

IRTeam@propanc.com
BUSINESS DESCRIPTION
Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer.

https://www.otcmarkets.com/stock/PPCB/security

Market Cap Market Cap
1,412,606
03/20/2023
Authorized Shares 10,000,000,000
03/13/2023
Outstanding Shares 2,354,342,830
03/13/2023
Restricted 194,354,827
03/13/2023
Unrestricted 2,159,988,003
03/13/2023
Held at DTC 2,159,948,895
03/13/2023
Float 100,616,724
05/17/2022